{"ok":true,"trend":{"id":728004,"platform":"news","region":"global","key":"novartis strikes up to $7.8 billion mrna deal with china's abogen","title":"Novartis strikes up to $7.8 billion mRNA deal with China's Abogen","url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNZWh5dEJ1LTdGU0pVQkdPODNVU2YybE5ielZvYkMyLTFnZWtxSU8xR21hXzVCVVhNb3NlQ3VIVnRqUFNZdjZNVjgtOHQybGNDTmlsVllPSWxoQ3B2WVN6Y3lxVHJ1ZDFKSi1jVktDbm84Zk9vSGtVVGNXUmNIektOYkN4azBxanNsbThzNTRCUGdQQ2lpbG9Zb19hSEpjbWdrVXpoSDV1b2NUNXZ6ZTA1MzhiTTN0QQ?oc=5","first_seen":"2026-10-02T11:28:12.180402Z","last_seen":"2026-10-02T18:19:13.716585Z","last_rank":34,"peak_rank":22,"last_volume":null,"peak_volume":0,"seen_count":6,"score":0.8415625,"category_hint":"labor","section":"business","category":"labor","summary":"Swiss drugmaker Novartis has agreed to a licensing deal worth up to $7.8 billion with China's Abogen Biosciences to develop mRNA-based therapies. The agreement gives Novartis access to Abogen's mRNA technology, highlighting growing Western pharmaceutical interest in Chinese biotech assets and keeping momentum behind mRNA platforms beyond vaccines.","why":"The scale of the deal and Big Pharma's push into Chinese biotech are drawing attention.","tone":"neutral","entities":["Novartis","Abogen Biosciences"],"summarized_at":"2026-10-02T17:32:42.875327Z","meta":{"via":"scan","lang":"en","term":"strike","source":"Reuters","published":"Fri, 02 Oct 2026 14:08:17 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Novartis signs up to $7.8 billion mRNA deal with China's Abogen","section_name":"Business","category_name":"Labor","timeline":[{"captured_at":"2026-10-02T11:28:12.180402Z","rank":22,"volume":null},{"captured_at":"2026-10-02T12:50:11.373319Z","rank":34,"volume":null},{"captured_at":"2026-10-02T14:12:12.500161Z","rank":23,"volume":null},{"captured_at":"2026-10-02T15:34:34.953980Z","rank":31,"volume":null},{"captured_at":"2026-10-02T16:56:32.894102Z","rank":36,"volume":null},{"captured_at":"2026-10-02T18:19:13.716585Z","rank":34,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNZWh5dEJ1LTdGU0pVQkdPODNVU2YybE5ielZvYkMyLTFnZWtxSU8xR21hXzVCVVhNb3NlQ3VIVnRqUFNZdjZNVjgtOHQybGNDTmlsVllPSWxoQ3B2WVN6Y3lxVHJ1ZDFKSi1jVktDbm84Zk9vSGtVVGNXUmNIektOYkN4azBxanNsbThzNTRCUGdQQ2lpbG9Zb19hSEpjbWdrVXpoSDV1b2NUNXZ6ZTA1MzhiTTN0QQ?oc=5","author":"Reuters","title":"Novartis strikes up to $7.8 billion mRNA deal with China's Abogen","snippet":null,"posted_at":"2026-10-02T10:57:13Z","likes":null}],"elsewhere":[],"window":"7d"}}